RecruitingPhase 2NCT05004610
Hypertonic Lactate After Cardiac Arrest
Sponsor
Erasme University Hospital
Enrollment
125 participants
Start Date
Feb 19, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The study is intended to test the hypothesis that sodium lactate infusion after resuscitation from a cardiac arrest will decrease the magnitude of brain damage, as measured by the serum biomarker concentration of NSE.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Age \> 18 years old
- Sustained (\> 20 minutes) return of spontaneous circulation (ROSC)
- Comatose (GCS \< 9)
- Time to ROSC \> 15'
Exclusion Criteria4
- Protected categories (Pregnant women)
- Anticipated withdrawal of support within 24 hours
- Traumatic cause of cardiac arrest
- Body weight at admission \> 120Kg
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGSodium Lactate Solution
continuous intravenous infusion of molar sodium lactate
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05004610
Related Trials
AI-powered ECG Analysis Using Willem™ Software in High-risk Cardiac Patients (WILLEM)
NCT0589071614 locations
intErnet-based iNterventions FOR Cardiac arrEst suRvivors
NCT063955582 locations
Study of the Occurrence of Cardiocirculatory Arrest as a Function of the Level of Hypoxemia During a Maastricht 3 Procedure
NCT0678072212 locations
Serious Game for Improving Targeted Temperature Management Knowledge and Situational Awareness in Critical Care Nurses
NCT072392061 location
Predictors for Survival and Good Neurological Outcome in E-CPR and Non CPR Treated Patients
NCT041987921 location